Nanobiotix Files Routine 6-K Disclosure
Ticker: NBTX · Form: 6-K · Filed: Apr 30, 2025 · CIK: 1760854
| Field | Detail |
|---|---|
| Company | Nanobiotix S.A. (NBTX) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: routine-filing, foreign-private-issuer, sec-disclosure
TL;DR
Nanobiotix filed a 6-K, just a routine update, no big news here.
AI Summary
Nanobiotix S.A. filed a Form 6-K on April 30, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal executive office in Paris, is required to file annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing indicates Nanobiotix is adhering to its reporting obligations as a foreign private issuer, which is standard for companies listed on US exchanges but based internationally.
Risk Assessment
Risk Level: low — This is a standard, routine filing by a foreign private issuer and does not contain new material information or financial data.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- Paris, France (location) — Principal executive office location
- April 2025 (date) — Reporting period
- 20250430 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
What is Nanobiotix S.A.'s filing status regarding annual reports?
Nanobiotix S.A. indicates it files annual reports under cover of Form 20-F.
Where is Nanobiotix S.A.'s principal executive office located?
The principal executive office of Nanobiotix S.A. is located at 60 Rue de Wattignies, 75012 Paris, France.
What is the Commission File Number for Nanobiotix S.A.?
The Commission File Number for Nanobiotix S.A. is 001-39777.
Does this filing contain specific financial results or operational updates?
No, this filing is a routine report of a foreign private issuer and does not appear to contain specific financial results or operational updates.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2025 regarding Nanobiotix S.A. (NBTX).